OverviewChartNewsTraderScreen

BVT Put 150 AMD 06.09.2024/  DE000VC059K7  /

Frankfurt Zert./VONT
9/2/2024  1:54:41 PM Chg.-0.150 Bid2:08:43 PM Ask2:08:43 PM Underlying Strike price Expiration date Option type
0.330EUR -31.25% 0.330
Bid Size: 40,000		 0.340
Ask Size: 40,000		 ADVANCED MIC.DEV. D... 150.00 - 9/6/2024 Put
TeleTrader 8/28 Dow down by 350 pts with tech sector in focus
GlobeNewswire 8/20 AMD to Present at the Deutsche Bank Technology Conference
GlobeNewswire 8/20 FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire 8/20 Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
TeleTrader 8/19 US closes higher on tech sell-off
TeleTrader 8/19 AMD to buy server maker ZT Systems for $4.9B
GlobeNewswire 8/19 AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire 8/16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 8/14 Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...
GlobeNewswire 8/12 Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire 8/12 Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 8/12 Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 8/12 AMD Completes Acquisition of Silo AI to Accelerate Development and Deployment of AI Models on AMD Ha...
GlobeNewswire 8/12 Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic M...
GlobeNewswire 8/12 Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar po...
GlobeNewswire 8/9 Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire 8/8 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 8/8 BOXX Workstations Feature New AMD Ryzen™ 9000 Series Processors
GlobeNewswire 8/8 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 8/8 Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 8/8 EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 8/8 YieldMax™ Launches Option Income Strategy ETF on Alibaba (BABA)
GlobeNewswire 8/7 Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2...
GlobeNewswire 8/7 Ocular Therapeutix™ Reports Second Quarter 2024 Results
GlobeNewswire 8/7 Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study...